Acute renal failure secondary to rosuvastatin-induced rhabdomyolysis

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Case report reveals rhabdomyolysis and acute renal failure post rosuvastatin increase in a 76-year-old woman, indicating risks of dosage changes.

Acute renal failure developed following an increase in rosuvastatin dosage, demonstrating potential adverse effects.
A 76-year-old woman experienced severe rhabdomyolysis, with associated muscle enzyme elevations leading to kidney issues.
The report details a case analysis, showcasing the clinical challenges of managing statin-induced rhabdomyolysis.
This case highlights the importance of monitoring for complications related to medication adjustments in older patients.

Mohammad et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Case report reveals rhabdomyolysis and acute renal failure post rosuvastatin increase in a 76-year-old woman, indicating risks of dosage changes.